Zevia PBC 8-K

What Happened
Zevia PBC announced that the Board appointed Suzanne Ginestro as an independent Class II director effective January 7, 2026. Ms. Ginestro will serve until the Company’s 2026 Annual Meeting of Stockholders when she will be up for re-election, and has been named to the Board’s Compensation Committee. Separately, director Justin Shaw notified the Company he will step down from the Board effective February 24, 2026; the resignation is not the result of any disagreement with the Company.

Key Details

• Appointment date: Suzanne Ginestro effective January 7, 2026.
• Term: Ms. Ginestro will serve until the 2026 Annual Meeting and stand for re-election.
• Committee role: Ms. Ginestro was appointed to the Board’s Compensation Committee.
• Compensation & protections: She will receive the Company’s standard non‑employee director compensation (as described in the 2025 proxy) and is expected to enter the standard director & officer indemnification agreement.
• Resignation: Justin Shaw will resign effective February 24, 2026; Company thanked him for his service.
• Disclosure: A press release announcing the appointment was furnished as an exhibit to the 8‑K.

Why It Matters
Board composition and committee memberships can affect oversight of strategy, executive pay and risk. Investors should note a Director change that adds a new independent member and shifts board makeup ahead of the 2026 annual meeting. The filing contains no disclosures of related-party transactions or disagreements leading to the resignation.